# Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

> **NCT03890614** · — · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 70 (estimated)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **OTHER:** Ancillary-Correlative - Creation of three-dimensional myeloma organoids using marrow aspirates

## Key facts

- **NCT ID:** NCT03890614
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-16
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03890614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03890614, "Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03890614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*